Novel drug extends survival for women with HR-positive metastatic breast cancer

[News]

The drug palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer, according to a large phase III clinical trial.

More... (https://www.news-medical.net/news/20181024/Novel-drug-extends-survival-for-women-with-HR-positive-metastatic-breast-cancer.aspx)